Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 3016 AL 3030

A Fresh Look at Huntingtin mRNA Processing in Huntington's Disease

Romo L, Mohn ES, Aronin N.

J Huntingtons Dis. 2018;7(2):101-108. doi: 10.3233/JHD-180292.

Salivary biomarkers for the diagnosis and monitoring of neurological diseases

Farah R, Haraty H, Salame Z, Fares Y, Ojcius DM, Said Sadier N.

Biomed J. 2018 Apr;41(2):63-87. doi: 10.1016/j.bj.2018.03.004. Epub 2018 May 10.

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Peres FF, Lima AC, Hallak JEC, Crippa JA, Silva RH, Abílio VC.

Front Pharmacol. 2018 May 11;9:482. doi: 10.3389/fphar.2018.00482. eCollection 2018.

IgLON5-Associated Encephalitis With Atypical Brain Magnetic Resonance Imaging and Cerebrospinal Fluid Changes

Montagna M, Amir R, De Volder I, Lammens M, Huyskens J, Willekens B.

Front Neurol. 2018 May 17;9:329. doi: 10.3389/fneur.2018.00329. eCollection 2018.

Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system

Zhong Z, Han J, Zhang J, Xiao Q, Hu J, Chen L.

Drug Des Devel Ther. 2018 May 24;12:1479-1489. doi: 10.2147/DDDT.S160776. eCollection 2018.

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

Franco-Iborra S, Vila M, Perier C.

Front Neurosci. 2018 May 23;12:342. doi: 10.3389/fnins.2018.00342. eCollection 2018.

Neuro-Cardio Mechanisms in Huntington's Disease and Other Neurodegenerative Disorders

Critchley BJ, Isalan M, Mielcarek M.

Front Physiol. 2018 May 23;9:559. doi: 10.3389/fphys.2018.00559. eCollection 2018.

Resting-state connectivity in neurodegenerative disorders: Is there potential for an imaging biomarker?

Hohenfeld C, Werner CJ, Reetz K.

Neuroimage Clin. 2018 Mar 16;18:849-870. doi: 10.1016/j.nicl.2018.03.013. eCollection 2018.

Epigenetic Regulation in Neurodegenerative Diseases

Berson A, Nativio R, Berger SL, Bonini NM.

Trends Neurosci. 2018 Sep;41(9):587-598. doi: 10.1016/j.tins.2018.05.005. Epub 2018 Jun 7.

The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases

Dupont AC, Largeau B, Guilloteau D, Santiago Ribeiro MJ, Arlicot N.

Contrast Media Mol Imaging. 2018 May 17;2018:7043578. doi: 10.1155/2018/7043578. eCollection 2018.

Cancer: From Wild-Type to Mutant Huntingtin

Thion MS, Humbert S.

J Huntingtons Dis. 2018;7(3):201-208. doi: 10.3233/JHD-180290.

A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders

Kurtis MM, Balestrino R, Rodriguez-Blazquez C, Forjaz MJ, Martinez-Martin P.

Front Neurol. 2018 May 29;9:369. doi: 10.3389/fneur.2018.00369. eCollection 2018.

Therapeutic strategies for targeting neurodegenerative protein misfolding disorders

Scannevin RH.

Curr Opin Chem Biol. 2018 Jun;44:66-74. doi: 10.1016/j.cbpa.2018.05.018. Epub 2018 Jun 11.

Unconventional Secretion and Intercellular Transfer of Mutant Huntingtin

Tang BL.

Cells. 2018 Jun 14;7(6):59. doi: 10.3390/cells7060059.

Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction

Lee HJ, Yoon YS, Lee SJ.

Cell Death Dis. 2018 Jun 15;9(7):712. doi: 10.1038/s41419-018-0749-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias